Elanco Animal Health [ELAN] vs Zoetis [ZTS] Detailed Stock Comparison

Elanco Animal Health Inc.

NYSE
Loading...

Zoetis Inc.

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 21 vital metrics comparison: Elanco Animal Health Inc. wins in 6 metrics, Zoetis Inc. wins in 14 metrics, with 0 ties. Zoetis Inc. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Elanco Animal Health Inc. Zoetis Inc. Better
P/E Ratio (TTM) 377.14 19.58 Zoetis Inc.
Price-to-Book Ratio 1.72 15.04 Elanco Animal Health Inc.
Debt-to-Equity Ratio 67.89 279.59 Elanco Animal Health Inc.
PEG Ratio 0.14 2.81 Elanco Animal Health Inc.
EV/EBITDA 16.68 13.96 Zoetis Inc.
Profit Margin (TTM) -4.92% 28.24% Zoetis Inc.
Operating Margin (TTM) 2.27% 34.69% Zoetis Inc.
EBITDA Margin (TTM) 2.27% 34.69% Zoetis Inc.
Return on Equity -3.67% 65.99% Zoetis Inc.
Return on Assets (TTM) 1.25% 15.26% Zoetis Inc.
Free Cash Flow (TTM) $284.00M $2.28B Zoetis Inc.
Dividend Yield N/A 1.21% N/A
1-Year Return 70.00% -53.31% Elanco Animal Health Inc.
Price-to-Sales Ratio (TTM) 2.39 5.26 Elanco Animal Health Inc.
Enterprise Value $15.14B $56.75B Zoetis Inc.
EV/Revenue Ratio 3.21 6.00 Elanco Animal Health Inc.
Gross Profit Margin (TTM) 51.49% 70.17% Zoetis Inc.
Revenue per Share (TTM) $10 $21 Zoetis Inc.
Earnings per Share (Diluted) $-0.47 $6.02 Zoetis Inc.
Beta (Stock Volatility) 1.88 0.97 Zoetis Inc.
Short % of Float 8.13% 4.06% Zoetis Inc.

Elanco Animal Health Inc. vs Zoetis Inc. Stock Performance Analysis

Loading Price Chart...

ELAN
ZTS

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Elanco Animal Health Inc.0.50%-2.67%10.73%2.56%13.07%6.79%
Zoetis Inc.1.51%2.25%-29.41%-35.01%-33.05%-36.91%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Elanco Animal Health Inc.70.00%160.82%-29.88%-30.70%-30.70%-30.70%
Zoetis Inc.-53.31%-51.29%-56.40%67.63%156.18%156.18%

Performance & Financial Health Analysis: Elanco Animal Health Inc. vs Zoetis Inc.

MetricELANZTS
Market Information
Market Cap i$11.18B$49.75B
Market Cap CategoryLarge capLarge cap
10 Day Avg. Volume i4,096,5392,727,710
90 Day Avg. Volume i5,352,8903,835,940
Last Close$24.17$167.10
52 Week Range$13.16 - $27.72$139.70 - $200.33
% from 52W High-12.81%-16.59%
All-Time High$37.61 (Sep 24, 2018)$249.27 (Dec 27, 2021)
% from All-Time High-35.74%-32.96%
Growth Metrics
Quarterly Revenue Growth0.12%0.03%
Quarterly Earnings Growth0.12%0.04%
Financial Health
Profit Margin (TTM) i-0.05%0.28%
Operating Margin (TTM) i0.02%0.35%
Return on Equity (TTM) i-0.04%0.66%
Debt to Equity (MRQ) i67.89279.59
Cash & Liquidity
Book Value per Share (MRQ)$13.17$7.84
Cash per Share (MRQ)$1.10$5.48
Operating Cash Flow (TTM) i$560.00M$2.90B
Levered Free Cash Flow (TTM) i$559.75M$1.79B
Dividends
Last 12-Month Dividend Yield iN/A1.21%
Last 12-Month Dividend iN/A$2.03

Valuation & Enterprise Metrics Analysis: Elanco Animal Health Inc. vs Zoetis Inc.

MetricELAN (Apr 23, 2026)ZTS (Apr 13, 2026)
Price Ratios
P/E Ratio (TTM) i377.1419.58
Forward P/E i19.3515.61
PEG Ratio i0.142.81
Price to Sales (TTM) i2.395.26
Price to Book (MRQ) i1.7215.04
Market Capitalization
Market Capitalization i$11.18B$49.75B
Enterprise Value i$15.14B$56.75B
Enterprise Value Metrics
Enterprise to Revenue i3.216.00
Enterprise to EBITDA i16.6813.96
Risk & Other Metrics
Beta i1.880.97
Book Value per Share (MRQ) i$13.17$7.84

Financial Statements Comparison: Elanco Animal Health Inc. vs Zoetis Inc.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricELAN (2025)ZTS (2025)
Revenue/Sales i4.72B9.47B
Cost of Goods Sold i2.12B2.67B
COGS % of Revenue i45.0%28.2%
Gross Profit i2.59B6.80B
Gross Margin i55.0%71.8%
Research & Development i368.00M698.00M
Operating Income (EBIT) i252.00M3.60B
Operating Margin i5.3%38.0%
EBITDA i913.00M4.17B
EBITDA Margin i19.4%44.1%
Pre-Tax Income i-224.00M3.36B
Pre-Tax Income % of Revenue i-4.8%35.5%
Income Tax i8.00M687.00M
Income Tax % of Revenue i0.2%7.3%
Net Income (Profit) i-232.00M2.67B
Profit Margin i-4.9%28.2%

Balance Sheet & Liquidity Metrics

MetricELAN (2025)ZTS (2025)
Cash & Equivalents i545.00M2.31B
Total Current Assets i3.46B6.77B
Total Current Assets % of Revenue i73.3%71.5%
Total Current Liabilities i1.60B2.24B
Total Current Liabilities % of Revenue i33.9%23.6%
Long-Term Debt i3.94B9.24B
Long-Term Debt % of Revenue i83.6%97.6%
Total Shareholders Equity i6.55B3.33B
Retained Earnings i-2.18B13.74B
Retained Earnings % of Revenue i-46.3%145.2%
Property, Plant & Equipment i1.33B288.00M

Cash Flow Statement Comparison

MetricELAN (2025)ZTS (2025)
Operating Cash Flow i489.00M2.78B
Operating Cash Flow % of Revenue i10.4%29.3%
Capital Expenditures i-276.00MN/A
Free Cash Flow i284.00M2.28B
FCF Margin i6.0%24.1%
Debt Repayment i-2.92B-1.35B
Common Stock Repurchase iN/A-3.24B

Short Interest & Institutional Ownership Analysis

MetricELANZTS
Shares Short i25.54M15.12M
Short Ratio i4.533.60
Short % of Float i8.13%4.06%
Shares Outstanding i496.98M424.93M
Float Shares i492.68M421.29M
% Held by Insiders i1.19%0.15%
% Held by Institutions i109.45%101.50%
% Held by Public i-10.64%-1.65%

Dividend Analysis & Yield Comparison: Elanco Animal Health Inc. vs Zoetis Inc.

MetricELANZTS
Last 12-Month Dividend iN/A$2.03
Last 12-Month Dividend Yield iN/A1.21%
3-Year Avg Annual Dividend iN/A$1.80
3-Year Avg Dividend Yield iN/A0.29%
3-Year Total Dividends iN/A$5.39
Ex-Dividend DateN/AJan 20, 2026